CHICAGO (Thomson Financial) – US researchers have devised a way to genetically disarm the deadly Ebola virus in a development that could speed research into a vaccine against the bug or drugs to treat people who have been infected with it, a study released Monday said.
The investigators discovered that by removing a single gene from the virus, they can prevent it from replicating or multiplying, effectively neutralizing the virus and making it much safer to study.